AbCellera Biologics Inc.ABCLNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-2.64%
202413.72%
202312.62%
202236.90%
2021209.55%
2020292.62%
201940.13%
20180.00%